The new CEO, Lance Alstodt, has a strong track rec

The new CEO, Lance Alstodt, has a strong track record for team building and success. The intent of the new team at BioRestorative Therapies is to create a successful Biotech company, not to pump and dump. That is nonsense of the highest order. BRTX has the Disc/Spine Program (brtxDISC) that may be able to be brought to market in the near future, something that most Biotech companies of their age may never have FDA approval to even attempt to do. Their stem-cell disk procedure bypassed the first stage approval because of high percentage of anecdotal success in preliminary testing. Be advised, this is what I consider to be a long-term investment with great appreciation potential. I believe that BRTX will make many an investor happy if they would just ignore the nonsensical posts in this chat room by those who know little to nothing about how all of this functions. When this company becomes a reporting entity, this stock is going to move up significantly, I repeat, this stock is going up....a lot! It is an absolute bargain at these prices. There is absolutely no doubt in my mind that this is a good bet.
Thank you for reading my post,
Pro-Advisor